Navigation Links
Dyadic International Reports 2010 Third Quarter Financial Results
Date:11/15/2010

. License fee revenue for the nine months ended September 30, 2010 decreased to $32,000 as compared to approximately $10.2 million for the nine months ended September 30, 2009. The decrease in license fee revenue for the three and nine month periods ended September 30, 2010 as compared to the same periods in 2009 was due to license fee revenue recognized in the third quarter of 2009 of approximately $9.9 million from Codexis, Inc. ("Codexis") pursuant to a non-exclusive license agreement between Codexis and Dyadic.

Research and development revenue for the third quarter ended September 30, 2010 decreased to approximately $64,000 as compared to approximately $298,000 for the third quarter ended September 30, 2009. Research and development revenue for the nine months ended September 30, 2010 decreased to approximately $618,000 as compared to approximately $3.9 million for the nine months ended September 30, 2009. The decrease in research and development revenue for the nine months ended September 30, 2010 as compared to the nine months ended September 30, 2009 was due to research and development revenue recognized in the first quarter of 2009 of approximately $3.3 million from Abengoa Bioenergy R&D, Inc. ("Abengoa") pursuant to a securities purchase agreement between Dyadic and Abengoa.

Net loss for the third quarter ended September 30, 2010 was approximately $1.4 million, or $(0.04) per basic and diluted share as compared to a net loss of approximately $654,000, or $(0.02) per basic and diluted share for the third quarter ended September 30, 2009. Net loss for the nine months ended September 30, 2010 was approximately $3.9 million, or $(0.13) per basic and diluted share as compared to net income of approximately $10.2 million, or $0.34 per basic and $0.31 per diluted share, for the nine months ended September 30, 2009.

At September 30, 2010, cash and cash equivalents were approximately $5.9 million as compared to approximately $8.4 million at
'/>"/>

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
2. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
3. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
4. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
5. Dyadic International Engages The Abraham Group as Strategic Advisor
6. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
7. Dyadic International Strengthens Management Team
8. Dyadic International Extends Collaboration With The Scripps Research Institute
9. International Technidyne Corporation Acquired by Warburg Pincus
10. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
11. Distinguished Scientist H. Mario Geysen Joins SRI International to Lead Combinatorial Sciences and Metabolic Diseases Research Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... At the request of the AMA, the ... for the public comment period (Docket No. FAA-2014-0396) for ... established by Congress as part of the FAA Modernization ... the new deadline for comments as September 23, 2014. ... published in the Federal Register on July 25, 2014, ...
(Date:7/24/2014)... Calif. , July 24, 2014  Now available ... to home. Rehealth Regenerative Therapies , located in ... and other physically active people a new health option: ... Regardless of age, countless patients suffer from joint ... activities, such as muscle tears, torn rotator cuff, tennis ...
(Date:7/24/2014)... to materialise. Yet, scientists are making progress in ... One such approach relies on quantum dotsa kind ... electric field. A new study demonstrates that changing ... (TQDs) with electrical impulses can help better control ... be used as quantum information units, which would ...
(Date:7/24/2014)... Your cell phone may stay charged ... storage capacity. , New research indicates that lithium-ion ... at Lawrence Livermore National Laboratory and ... components will perform as electrodes. , The growing ... for higher-performance batteries. Several key characteristics of lithium-ion ...
Breaking Biology Technology:FAA Grants Comment Extension at the Request of AMA 2Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Getting More Life out of Lithium-ion Batteries 2
... Jan. 6 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: ... corporate activities. Pursuant to a previously announced restructuring ... the purpose of enhancing shareholder value. This process ... including the sale of the Company, a merger ...
... has appointed Andrew Chisholm to the position of Vice ... of energy and expertise to Accumetrics. His experience ... of our market penetration," says Timothy I. Still, President ... diagnostics industry and his relationships with distributors make him ...
... (OTC Bulletin Board: BSTC), a biopharmaceutical company developing first ... has received notification from The NASDAQ Stock Market LLC ... on the NASDAQ Global Market. The Company,s common stock ... market open under the symbol "BSTC" and will end ...
Cached Biology Technology:Vasogen Provides Corporate Update 2Vasogen Provides Corporate Update 3Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics 2BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market 2
(Date:7/25/2014)... 25, 2014 Biometrics industry expands ... to digital technology for online & commerce payments while ... (NASDAQ: GOOG ), LifeLock Inc. (NYSE: ... ), Apple Inc. (NASDAQ: AAPL ) and ... NXTD) a biometric authentication company focused on the growing ...
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... native animal species for food or commercial food sale, ... in the decline of many species of primates and ... more than half of the species being consumed are ... surveying not only the meat made available for sale ... forest by hunters and brought to villages for consumption, ...
Breaking Biology News(10 mins):Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4
... Scientists here have made a major discovery that sheds ... natural killer (NK) cells, powerful but somewhat mysterious components ... line of defense against cancer and infectious diseases. , ... are generated in bone marrow, but Michael Caligiuri, director ...
... vanishingly small realm of molecules and atoms may not ... after all. In fact, research at the National Institute ... version of the optical microscope might be able to ... fraction of the wavelength of visible light. , In ...
... Center scientists have discovered a potential new drug that ... one-third of all cancers. The scientists showed they could ... this new compound, called cysmethynil. , Their finding, reported ... the National Academy of Sciences, is the first step ...
Cached Biology News:Scientists identify new model Of NK cell development 2Scientists identify new model Of NK cell development 3Devising Nano Vision for an Optical Microscope 2Newly Discovered Compound Blocks Known Cancer-Causing Protein 2Newly Discovered Compound Blocks Known Cancer-Causing Protein 3
... discovery projects require screening through a ... clinically relevant data from normal biologic ... is now available to help better ... data flood inherent to biomarker discovery. ...
... Sigmas FLAG Immunoprecipitation kit allows ... elution of an active FLAG-tagged protein. ... affinity gel, which is a highly ... agarose resin. The use of affinity ...
... Shaker , ,Product Information , ... GyroTwister GX-1000 is extremely efficient, yet gentle, ... as well as staining gels, hybridization and ... across a broad range. A nonslip rubber ...
... Data System (CDS) now provides integrated ... data processing and reporting for the ... The companys innovative HPLC instrument has ... of Thermo Scientific Hypersil GOLD 1.9 ...
Biology Products: